JPS6051473B2 - 4-substituted phenyl phthalazine derivatives - Google Patents
4-substituted phenyl phthalazine derivativesInfo
- Publication number
- JPS6051473B2 JPS6051473B2 JP52098823A JP9882377A JPS6051473B2 JP S6051473 B2 JPS6051473 B2 JP S6051473B2 JP 52098823 A JP52098823 A JP 52098823A JP 9882377 A JP9882377 A JP 9882377A JP S6051473 B2 JPS6051473 B2 JP S6051473B2
- Authority
- JP
- Japan
- Prior art keywords
- phthalazine
- phenyl
- reaction
- isopropylaminopropoxy
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
【発明の詳細な説明】
本発明はβ一遮断作用並びに血圧降下作用を有する一般
式/゛’−ーー 1
目 −1−0CH2CHCH。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a compound of the general formula /゛'--1-1-0CH2CHCH which has a β-blocking effect and a blood pressure lowering effect.
NH−−R\ノ
イヘ\/ユ<N
□1−占
一゛T’
(式中Rは直鎖状または分枝状低級アルキル基を意味し
、フェニル基上の置換基はO、、mまたはp位にあるこ
とを意味する)で表わされる化合物又はその塩類に関す
るものである。NH--R\Neihe\/Yu<N □1-Tenichi゛T' (In the formula, R means a linear or branched lower alkyl group, and the substituents on the phenyl group are O, , m or (meaning being in the p-position) or its salts.
本発明化合物としては例えば次の如きもの並びにその塩
類を挙げる事ができる。Examples of the compounds of the present invention include the following and their salts.
(1)1−ヒドラジノー4−〔2−(2−ハイドカオキ
シー3−イソプロピルアミノプロポキシ)フェニル〕フ
タラジン(2) 1−ヒドラジノー4−〔2−(2−ハ
イドロ″ オキシー3−三級ブチルアミノプロポキシ)
フェニル〕フタラジン(3) 1−ヒドラジノー4−〔
3−(2−ハイドロオキシー3−イソプロピルアミノプ
ロポキシ)フェニル〕フタラジン・(4)1−ヒドラジ
ノー4−〔4−(2−ハイドロオキシー3−イソプロピ
ルアミノプロポキシ)フェニル〕フタラジン本発明の化
合物は種々の方法により製造し得るが、次に示す経路を
、その代表例として説明する。(1) 1-hydrazino 4-[2-(2-hydrocaoxy-3-isopropylaminopropoxy)phenyl]phthalazine (2) 1-hydrazino 4-[2-(2-hydro'' oxy-3-tertiary butylaminopropoxy) )
phenyl]phthalazine (3) 1-hydrazine 4-[
3-(2-Hydroxy-3-isopropylaminopropoxy)phenyl]phthalazine (4) 1-hydrazino 4-[4-(2-hydroxy-3-isopropylaminopropoxy)phenyl]phthalazine The compounds of the present invention can be prepared in various ways. However, the following route will be explained as a typical example.
(Yは水酸基の保護基を、xはハロゲン原子を、R゛は
水素原子を意味し、Rは前記と同じものを意味する。(Y means a hydroxyl protecting group, x means a halogen atom, R' means a hydrogen atom, and R means the same as above.
)すなわち、ます文献既知の方法あるいは類似の方法に
よつて合成された2−(メトキシベンゾイル)安息香酸
(■)とヒドラジンーヒドラートを適当な溶媒の存在下
又は非存在下に加熱反応させる事により4−(メトキシ
フェニル)フタラジノン(■)を合成する。次いで(■
)を濃臭化水素酸、沃化水素酸等の鉱酸類を用いて脱メ
チル化し、4−(ハイドロオキシフェニル)フタラジノ
ン(■)とし、更に適当な保護基(アセチル基、ベンゾ
イル基等)を用いて遊離水酸基を保護する。保護基とし
て、例えばアセチル基を適用する場合は、無水酢酸一ピ
リジンの如き通常のアセチル化試剤を用いればよい。) That is, 2-(methoxybenzoyl)benzoic acid (■) synthesized by a method known in the literature or a similar method is heated to react with hydrazine-hydrate in the presence or absence of an appropriate solvent. 4-(methoxyphenyl)phthalazinone (■) is synthesized by the following steps. Then (■
) is demethylated using mineral acids such as concentrated hydrobromic acid and hydriodic acid to form 4-(hydroxyphenyl)phthalazinone (■), and a suitable protecting group (acetyl group, benzoyl group, etc.) is added. to protect free hydroxyl groups. For example, when an acetyl group is used as a protecting group, a common acetylating agent such as acetic anhydride monopyridine may be used.
次いで(V)にオキシ塩化燐の如き通常のハロゲン化剤
を反応せしめて1−ハロゲノフタラジン誘導体(■)に
導いた後、加水分解反応により脱保護基を行ない、1−
ハロゲノー4−(ハイドロオキシフェニル)フタラジン
(■)を合成する。この様にして得られた(■)とエピ
ハロゲンヒドリン類を適当な溶媒中にて、炭酸カリ等の
適当な脱酸剤の存在下に反応せしめ、1−ハロゲノー4
−〔(2・3−エポキシプロポキシ)フェニル〕フタラ
ジン(■)を得る。更に、(■)とアミン類とを適当な
溶媒中で反応させ(■)とし、次いで、ヒドラジンーヒ
ドラートを適当な溶媒の存在又は非存在下に反応せしめ
る事により、1−ヒドラジノー4−〔(2−ヒドロキシ
ー3一置換アミノプロポキシ)フェニル〕フタラジン(
1)が製造される。上記説明中に用いた「適当な溶媒」
とは、原料物質を若干でも溶解し得るもので、反応試剤
と反応しないものであればよく、特別なものを示す訳で
はない。Next, (V) is reacted with a conventional halogenating agent such as phosphorus oxychloride to obtain a 1-halogenophthalazine derivative (■), and then the protecting group is removed by a hydrolysis reaction to form 1-
Synthesize halogeno-4-(hydroxyphenyl)phthalazine (■). The thus obtained (■) and epihalogenhydrin were reacted in an appropriate solvent in the presence of an appropriate deoxidizing agent such as potassium carbonate, and 1-halogeno-4
-[(2,3-epoxypropoxy)phenyl]phthalazine (■) is obtained. Furthermore, by reacting (■) with an amine in an appropriate solvent to form (■), and then reacting hydrazine-hydrate in the presence or absence of an appropriate solvent, 1-hydrazine 4-[ (2-Hydroxy-3-monosubstituted aminopropoxy)phenyl]phthalazine (
1) is manufactured. "Appropriate solvent" used in the above explanation
It is not necessary to refer to anything special, as long as it can dissolve the raw material even slightly and does not react with the reaction reagent.
又、反応温度も室温乃至200℃程度の通常の化学反応
に用いる温度範囲を示すものであlり、反応時間も3紛
乃至印時間程度てあり、反応温度と関連して適宜に増減
される。後述の実施例は単なる例示であつて、反応試剤
、反応条件を規定したものではなく、又、本発明化合物
は、これ以外の種々の方法によつて製造ノすることも可
能である。In addition, the reaction temperature indicates the temperature range used for ordinary chemical reactions, from room temperature to about 200°C, and the reaction time is also about 3 minutes to 3 hours, and can be increased or decreased as appropriate in relation to the reaction temperature. . The Examples described below are merely illustrative and do not define the reaction reagents or reaction conditions, and the compounds of the present invention can also be produced by various other methods.
本発明化合物は前記の如くβ一遮断作用並びに血圧降下
作用を併有する為、他の降圧剤で、しばしば見られる副
作用である頻脈を起すことなく、血圧を降下させ得る点
で極めて有用な薬剤である。 2例
えば、1−ヒドラジノー4−〔2−(2−ハイドロオキ
シー3−イソプロピルアミノプロポキシ)フェニル〕フ
タラジンは無麻酔の自然発症高血圧ラット(SHR)に
100m91k9経口投与した場合、3時間後から血圧
下降が発現し始め、6時間二後に最大下降(22±4.
1咽Hgpく0.01)に達し、有意の効果が2@間以
上持続した。なお、降圧に先行して投与1時間後まで軽
度(〈1DI1r1nHg)の血圧上昇がみられた。こ
の場合、同−SHRで同時に測定した心拍数は殆んど不
変ないしは徐脈傾!向を示し、降圧と頻脈との分離は極
めて良好であつた。また本化合物(300μYIkg、
I.v.)は麻酔犬において、イソプロテレノール(イ
).21LyIkg、1.v.)による拡張期血圧の下
降および心拍数・心筋収縮力の増加を30〜40%抑制
し、交感神経β−ー遮断活性が明らかに認められた。本
発明化合物は、通常、経口剤、注射剤等の剤型で使用さ
れるが、その目的に応じて遊離型又は塩が使用される。
塩としては、塩酸塩、硫酸塩、臭化水素酸塩、マレイン
酸塩等の無機及び有機酸塩があげられる。以下に本発明
化合物の製造実施例を示すが、本特許は、これに限定さ
れるものではない。As mentioned above, the compound of the present invention has both a β-blocking action and a blood pressure lowering action, so it is an extremely useful drug in that it can lower blood pressure without causing tachycardia, which is a side effect often seen with other antihypertensive drugs. It is. 2 For example, when 1-hydrazino-4-[2-(2-hydroxy-3-isopropylaminopropoxy)phenyl]phthalazine was orally administered at 100m91k9 to unanesthetized spontaneously hypertensive rats (SHR), the blood pressure decreased after 3 hours. It started to appear and reached its maximum decline after 6 hours (22±4.
The pharyngeal Hgp reached 0.01), and the significant effect lasted for more than 2 hours. It should be noted that a slight increase in blood pressure (<1DI1r1nHg) was observed prior to the decrease in blood pressure until 1 hour after administration. In this case, the heart rate measured at the same time with the same SHR is almost unchanged or has a tendency to bradycardia! The results showed an extremely good separation between hypotension and tachycardia. In addition, this compound (300μYIkg,
I. v. ) in anesthetized dogs, isoproterenol (a). 21LyIkg, 1. v. ), the decrease in diastolic blood pressure and increase in heart rate and myocardial contractile force were inhibited by 30-40%, and sympathetic β-blocking activity was clearly observed. The compound of the present invention is usually used in the form of oral preparations, injection preparations, etc., and free forms or salts are used depending on the purpose.
Examples of salts include inorganic and organic acid salts such as hydrochloride, sulfate, hydrobromide, maleate, and the like. Examples of manufacturing the compounds of the present invention are shown below, but the scope of this patent is not limited thereto.
実施例1
1−ヒトラジノー4−〔2−(2−ハイドロオキシー3
−イソプロピルアミノプロポキシ)フェニル〕フタラジ
ン2−(2−メトキシベンゾイル)安息香酸5q1ヒド
ラジンヒドラート4q1エタノール70mLの混合物を
1時間、加熱還流後、反応液を減圧濃縮し、析出せる結
晶を濾取し、メタノールより再結晶し、融点244〜2
45℃の4−(2−メトキシフェニル)フタラジノン3
.5y(68.8%)を得た。Example 1 1-Hytoradino 4-[2-(2-hydroxy-3
-isopropylaminopropoxy)phenyl]phthalazine 2-(2-methoxybenzoyl)benzoic acid 5q1 hydrazine hydrate 4q1 A mixture of 70 mL of ethanol was heated under reflux for 1 hour, the reaction solution was concentrated under reduced pressure, and the precipitated crystals were collected by filtration, Recrystallized from methanol, melting point 244-2
4-(2-methoxyphenyl)phthalazinone 3 at 45°C
.. 5y (68.8%) was obtained.
) このメトキシ体4.75yに150m1の濃臭化水
素酸を加え4時間170℃で還流し、反応液を濃縮乾固
し、さらに水を加え濃縮乾固を都合3回くりかえす。) Add 150 ml of concentrated hydrobromic acid to 4.75y of this methoxy compound, reflux at 170°C for 4 hours, concentrate the reaction solution to dryness, add water, and repeat the concentration to dryness three times in total.
残査を水より再結晶して4−(2−ハイドロオキシフェ
ニル)フタラジノン4.50q(99%)を得た。この
ものの4.15gと無水酢酸1.789及びピリジン7
0m1を加え合せ、室温で一夜攪拌し、反応液を氷水中
に注ぎ析出する結晶を濾取し、融点222〜224℃の
4−(2−アセトキシフェニル)フタラジノン4.18
y(85.7%)を得た。The residue was recrystallized from water to obtain 4.50q (99%) of 4-(2-hydroxyphenyl)phthalazinone. 4.15 g of this, 1.789 acetic anhydride and 7 pyridine
The reaction mixture was stirred overnight at room temperature, the reaction mixture was poured into ice water, and the precipitated crystals were collected by filtration.
y (85.7%) was obtained.
1 アセトキシ体3.980q1ジクロルエタン70m
t1オキシ塩化リン2.395fを加え合せ2.峙間還
流し、η℃上原料のスポットが消失した後、反応液を氷
水中に注ぎ、炭酸ソーダ水溶液(20y/100y水)
を加え中和。1 Acetoxy compound 3.980q1 dichloroethane 70m
Add 2.395f of t1 phosphorus oxychloride 2. After refluxing for a few seconds and the spot of the raw material disappearing at η℃, the reaction solution was poured into ice water and added to a sodium carbonate aqueous solution (20y/100y water).
Add to neutralize.
有機層と水層とを分離し、有機層は水洗、乾燥後留去し
、残査をシリカカラムクロマトにて精製し、TLCで単
一スポットの1−クロロー4−(2−アセトキシフェニ
ル)フタラジン3.40y(80.2%)を得る。融点
126〜127℃。バイルシユタイン反応十。e この
アセトキシ体3.02fを95%エタノール45m1に
溶解後、等モルの水酸化カリウムを加えて室温て一夜攪
拌する。The organic layer and the aqueous layer were separated, and the organic layer was washed with water, dried, and then distilled off. The residue was purified using silica column chromatography, and a single spot of 1-chloro-4-(2-acetoxyphenyl)phthalazine was analyzed by TLC. Obtain 3.40y (80.2%). Melting point: 126-127°C. Weilstein reaction ten. e After dissolving 3.02f of this acetoxy compound in 45 ml of 95% ethanol, an equimolar amount of potassium hydroxide was added and the mixture was stirred overnight at room temperature.
室温で反応液を減圧濃縮し、?塩酸で中和し、水を加え
析出する結晶を濾取し、100℃減圧乾燥して、融点1
76.5℃の1−クロロー4−(2−ヒドロキシフェニ
ル)フタラジン2.58y(95%)を得た。f この
ものの2.017fとエピブロモヒドリン3.07m1
1炭酸カリウム1.27y1メチルエチルケトン51.
9mLを加え合せ1時間還流する。Concentrate the reaction solution under reduced pressure at room temperature. Neutralize with hydrochloric acid, add water, collect the precipitated crystals by filtration, dry at 100°C under reduced pressure, and reduce the melting point to 1.
2.58y (95%) of 1-chloro-4-(2-hydroxyphenyl)phthalazine was obtained at 76.5°C. f 2.017f of this and 3.07ml of epibromohydrin
1 Potassium Carbonate 1.27y1 Methyl Ethyl Ketone 51.
Add 9 mL and reflux for 1 hour.
L℃上原料のスポットが消失後、反応液を濾過し、濾液
を濃縮乾固する。残査をシリカゲルクロマトにて精製し
、油状の1−クロロー4−(2一(2・3−エポキシプ
ロポキシ)フェニル)フタラジン1.6y(65.1%
)を得た。g エポキシ体1.50yにイソプロピルア
ミン5.0m1及びメタノール40mLを加え合せ30
分還流する。TLC上原料のスポットが消えた後反応液
を濃縮し、残査をシリカゲルカラムクロマトにて精製し
、TLC単一スポットの1−クロロー4−(2−(2−
ヒドロキシー3−イソプロピルアミノプロポキシ)フェ
ニル)フタラジン1.115f(62.5%)を得た。
バイルシユタイン反応+。h このものの1.104y
にヒドラジンヒドラート5.94ダ及びエタノール28
.8m1を加え合せ、窒素ガス下100℃2紛間反応さ
せる。After the spot of the starting material disappears at L°C, the reaction solution is filtered, and the filtrate is concentrated to dryness. The residue was purified by silica gel chromatography to obtain oily 1-chloro-4-(2-(2,3-epoxypropoxy)phenyl)phthalazine 1.6y (65.1%
) was obtained. g Add 5.0ml of isopropylamine and 40mL of methanol to 1.50y of epoxy body and mix 30
Reflux. After the starting material spot disappeared on TLC, the reaction solution was concentrated, and the residue was purified using silica gel column chromatography.
Hydroxy-3-isopropylaminopropoxy)phenyl)phthalazine 1.115f (62.5%) was obtained.
Weilstein reaction +. h This thing's 1.104y
hydrazine hydrate 5.94 da and ethanol 28
.. Add 8 ml of the mixture and react at 100°C under nitrogen gas.
TLC上原料のスポットがほとんど消えた後反応液をで
きるだけ低温で濃縮乾固する。残査に氷水を加えクロロ
ホルムで抽出し、クロロホルム層を水洗、乾燥、留去す
る。残査をクロロホルム−エーテルより再結晶し、融点
156〜158℃(分解)の1−,ヒドラジノー4−(
2−(2−ヒドロキシー3−イソプロピルアミノプロポ
キシ)フェニル)フタラジンの黄色晶560m9(51
.3%)を得た。バイルシユタイン反応−。元素分析C
2OH25O2N5として 2理論値:C
65.37、H6.8眠Nl9.O6実測値:C65.
lO..H6.8l、Nl8.78NMRスペクトル(
溶媒DMSO一山、内部規準物質TMSlδ値(Ppm
))実施例2
1−ヒドラジノー4−〔3−(2−ハイドロオキシー3
−イソプロピルアミノプロポキシ)フェニル〕フタラジ
ンA4−(3−メトキシフェニル)フタラジン実施例1
、aと同様の方法により、2−(3ーメトキシベンゾイ
ル)安息香酸15y1ヒドラジンヒドラード12y1エ
タノール150m1を用い、目的物10.2f(67.
4%)を得た。After the spot of the starting material almost disappeared on TLC, the reaction solution was concentrated to dryness at the lowest possible temperature. Ice water is added to the residue, extracted with chloroform, and the chloroform layer is washed with water, dried, and evaporated. The residue was recrystallized from chloroform-ether to give 1-, hydrazino-4-(
Yellow crystals of 2-(2-hydroxy-3-isopropylaminopropoxy)phenyl)phthalazine 560 m9 (51
.. 3%). Weilstein reaction. Elemental analysis C
2 Theoretical value as 2OH25O2N5: C
65.37, H6.8 sleep Nl9. O6 actual value: C65.
lO. .. H6.8l, Nl8.78NMR spectrum (
One mountain of solvent DMSO, internal reference substance TMSlδ value (Ppm
)) Example 2 1-hydrazino 4-[3-(2-hydroxy-3
-isopropylaminopropoxy)phthalazine A4-(3-methoxyphenyl)phthalazine Example 1
, by the same method as in a, using 2-(3-methoxybenzoyl)benzoic acid 15y1 hydrazine hydrade 12y1 ethanol 150ml, the target product 10.2f (67.
4%).
融点170〜172′C(メタノールより再結晶)。B
4−(3−ハイドロオキシフェニル)フタラジノン上に
得られた4−(3−メトキシフェニル)フタラジノン8
.48yを濃臭化水素酸300m1に懸濁し、6時間、
加熱還流する。Melting point 170-172'C (recrystallized from methanol). B
4-(3-methoxyphenyl)phthalazinone obtained on 4-(3-hydroxyphenyl)phthalazinone 8
.. 48y was suspended in 300ml of concentrated hydrobromic acid for 6 hours.
Heat to reflux.
冷後、析出晶を濾取、水洗し、メタノールより再結晶し
て融点288〜291℃の目的物6.80f(84.9
%)を得た。C4−(3−アセトキシフェニル)フタラ
ジノン上に得られた4−(3−ハイドロオキシフェニル
)フタラジノン238Tn9を用い、実施例1、cと同
様の反応を行ない、目的物208mg(74.1%)を
得た。After cooling, the precipitated crystals were collected by filtration, washed with water, and recrystallized from methanol to obtain the desired product 6.80f (84.9
%) was obtained. Using 4-(3-hydroxyphenyl)phthalazinone 238Tn9 obtained on C4-(3-acetoxyphenyl)phthalazinone, the same reaction as in Example 1, c was carried out to yield 208 mg (74.1%) of the target product. Obtained.
融点204〜206℃。j11−クロルー4−(3−ア
セトキシフェニル)フタラジン上に得られた4−(3−
アセトキシフェニル)フタラジノン4.72yを用い、
実施例1、dと同様の反応を行ない、目的物4.23y
(84.2%)を得た。Melting point 204-206°C. 4-(3-
Using acetoxyphenyl)phthalazinone 4.72y,
The same reaction as in Example 1, d was carried out to obtain the target product 4.23y.
(84.2%) was obtained.
融点129〜130℃。1−クロルー4−(3−ハイド
ロオキシフェニル)フタラジン上に得られた1−クロル
ー4−(3−アセトキシフェニル)フタラジジン4.2
3yを用い実施例1、eと同様に行い、目的物3.55
y(97.7%)を得た。Melting point: 129-130°C. 1-chloro-4-(3-acetoxyphenyl)phthalazidine obtained on 1-chloro-4-(3-hydroxyphenyl)phthalazine 4.2
3y was carried out in the same manner as in Example 1, e, and the target object was 3.55.
y (97.7%) was obtained.
融点187〜188℃。1−クロルー4−〔3−(2・
3−エポキシプロポキシ)フェニル〕フタラジン上に得
られた1−クロルー4−(3−ハイドロオキシフェニル
)フタラジン3.55y1エピブロムヒドリン9.48
y10.2NK0H−95%エタノール83m1を加え
合せ、室温にて2.5日攪拌した。Melting point: 187-188°C. 1-chlororu4-[3-(2.
1-chloro-4-(3-hydroxyphenyl)phthalazine obtained on 3-epoxypropoxy)phenyl]phthalazine 3.55y1 epibromohydrin 9.48
y10.2NKOH-83ml of 95% ethanol was added and stirred at room temperature for 2.5 days.
析出せる結晶を濾取しクロロホルムに溶解し、不溶物を
濾去後、シリカゲルカラムクロマトにて精製し、目的物
2.43y(56%)を得た。融点142〜144℃。
g11−クロルー4−〔3−(2−ハイドロオキシー3
−イソプロピルアミノプロポキシ)フェニル〕フタラジ
ン上に得られた1−クロルー4−〔3−(2・3−エポ
キシプロポキシ)フェニル)フタラジン1.73fを用
い、実施例1、gと同様に反応を行ない、油状物として
、目的物1.88q(91%)を得た。The precipitated crystals were collected by filtration and dissolved in chloroform, and after filtering off insoluble materials, the product was purified by silica gel column chromatography to obtain the desired product 2.43y (56%). Melting point: 142-144°C.
g11-chloro-4-[3-(2-hydroxy-3
Using 1.73f of 1-chloro-4-[3-(2,3-epoxypropoxy)phenyl)phthalazine obtained on -isopropylaminopropoxy)phenyl]phthalazine, the reaction was carried out in the same manner as in Example 1, g. 1.88q (91%) of the desired product was obtained as an oil.
h11−ヒドラジノー4−〔3−(2−ハイドロオキシ
ー3−イソプロピルアミノプロポキシ)フェニル〕フタ
ラジン上に得られた1−クロルー4−〔3−(2ーハイ
ドロオキシー3−イソプロピルアミノプロポキシ)フェ
ニル〕フタラジン1.3yを用い、実施例1、hと同様
に反応を行ない、1−ヒドラジノー4−〔3−(2−ハ
イドロオキシー3−イソプロピルアミノプロポキシ)フ
ェニル〕フタラジンの黄色結晶810mg(63.3%
)を得た。h11-Hydrazino 4-[3-(2-hydroxy-3-isopropylaminopropoxy)phenyl]phthalazine obtained on 1-chloro-4-[3-(2-hydroxy-3-isopropylaminopropoxy)phenyl]phthalazine 1 The reaction was carried out in the same manner as in Example 1, h using .3y to give 810 mg (63.3%) of yellow crystals of 1-hydrazino-4-[3-(2-hydroxy-3-isopropylaminopropoxy)phenyl]phthalazine.
) was obtained.
元素分析C2Oll2,O2Nとして
理論値:C65.37、H6.8氏Nl9.O6実測値
:C65.3O..H6.7次Nl8.82NMRスペ
クトル(溶媒CDCl3、内部基準物質TMSlδ値(
Ppm))8位H7.8〜8.1(1H..m)
実施例3
1−ヒドラジノー4−〔4−(2−ハイドロオキシー3
−イソプロピルアミノプロポキシ)フェニル〕フタラジ
ンA4−(4−メトキシフェニル)フタラジノン実施例
1、aと同様の方法により、2−(4ーメトキシベンゾ
イル)安息香酸840mgを用いて反応を実施し、目的
物620mg(73.2%)を得た。Theoretical value as elemental analysis C2Oll2, O2N: C65.37, H6.8 Mr.Nl9. O6 actual value: C65.3O. .. H6.7th order Nl8.82 NMR spectrum (solvent CDCl3, internal reference material TMSlδ value (
Ppm)) 8-position H7.8-8.1 (1H..m) Example 3 1-hydrazino 4-[4-(2-hydroxy-3
-isopropylaminopropoxy)phenyl]phthalazine A4-(4-methoxyphenyl)phthalazinone A reaction was carried out using 840 mg of 2-(4-methoxybenzoyl)benzoic acid in the same manner as in Example 1, a, resulting in 620 mg of the desired product. (73.2%) was obtained.
融点241〜243′COb4−(4−ハイドロオキシ
フェニル)フタラジノン上の様にして得られた4−(4
−メトキシフェニル)フタラジノン7.56yを用い、
実施例1、bと同様に行ない、目的物6.4y(89.
6%)を得た。Melting point 241-243'COb4-(4-hydroxyphenyl)phthalazinone 4-(4-
-methoxyphenyl)phthalazinone 7.56y,
The procedure was carried out in the same manner as in Example 1, b, and the target object was 6.4y (89.
6%).
メタノールより再結晶し、融点301〜306℃。4−
(4−アセトキシフェニル)フタラジノン上に得られた
4−(4−ハイドロオキシフェニル)フタラジノン4.
76yを用い、実施例1、cの如く反応を行ない、目的
物5.06y(90.4%)を得た。Recrystallized from methanol, melting point 301-306°C. 4-
4-(4-hydroxyphenyl)phthalazinone obtained on (4-acetoxyphenyl)phthalazinone 4.
Using 76y, the reaction was carried out as in Example 1, c, to obtain the target product 5.06y (90.4%).
融点258℃。11−クロルー4−(4−アセトキシフ
ェニル)フタラジン上に得られた4−(4−アセトキシ
フェニル)フタラジノン3.42yを用い、実施例1、
dと同様に反応を行ない、目的物2.96y(81.3
%)を得た。Melting point: 258°C. Using 3.42y of 4-(4-acetoxyphenyl)phthalazinone obtained on 11-chloro-4-(4-acetoxyphenyl)phthalazine, Example 1,
The reaction was carried out in the same manner as in d, and the target product was 2.96y (81.3y).
%) was obtained.
融点182〜183℃。1−クロルー4−(4−ハイド
ロオキシフェニル)フタラジン上に得られた1−クロル
ー4−(4−アセトキシフェニル)フタラジン2.96
yをメタノール50mtに溶解し、NNaOHlOml
を徐々に加える。Melting point: 182-183°C. 1-chloro-4-(4-acetoxyphenyl)phthalazine obtained on 1-chloro-4-(4-hydroxyphenyl)phthalazine 2.96
Dissolve y in 50 mt of methanol and add NNaOHlOml
Add gradually.
室温下、3時間攪拌後、NHClにて中和し、析出せる
結晶を濾取し、メタノールより再結晶し、融点300℃
以上を示す目的物2.15y(84.4%)を得た。1
1−クロルー4−〔1−(2●3−エポキシプロポキシ
)フェニル〕フタラジン上に得られた1−クロルー4−
(4−ハイドロオキシフェニル)フタラジン2.05y
を0.2NK0H−95%エタノール48m1に溶解し
、エピクロルヒドリン3.70yを加え、室温下、一夜
攪拌した。After stirring for 3 hours at room temperature, it was neutralized with NHCl, the precipitated crystals were collected by filtration, and recrystallized from methanol, with a melting point of 300°C.
A target product 2.15y (84.4%) showing the above was obtained. 1
1-chloro-4-[1-(2●3-epoxypropoxy)phenyl]phthalazine obtained on 1-chloro-4-
(4-hydroxyphenyl)phthalazine 2.05y
was dissolved in 48 ml of 0.2NKOH-95% ethanol, 3.70 y of epichlorohydrin was added, and the mixture was stirred at room temperature overnight.
析出せる結晶を濾取し、目的物2.04y(81.5%
)を得た。融点167〜169℃。−!1−クロルー4
−〔4−(2−ハイドロオキシー3−イソプロピルアミ
ノプロポキシ)フェニル〕フタラジン上に得られた1−
クロルー4−〔4−(2・3エポキシプロポキシ)フェ
ニル〕フタラジン.37fを用い、実施例1、gと同様
に反応を行な,)、目的物1.10y(67.2%)を
得た。The precipitated crystals were collected by filtration, and the target product 2.04y (81.5%
) was obtained. Melting point: 167-169°C. -! 1-Chloroux 4
1- obtained on -[4-(2-hydroxy-3-isopropylaminopropoxy)phenyl]phthalazine
Chloro-4-[4-(2,3 epoxypropoxy)phenyl]phthalazine. Using 37f, the reaction was carried out in the same manner as in Example 1, g) to obtain the desired product 1.10y (67.2%).
メタノール辷り再結晶し、融点158〜160℃。h1
1−ヒドラジノー4−〔4−(2−ハイドロオキシー3
−イソプロピルアミノプロポキシ)フェニル〕フタラジ
ン上に得られた1−クロルー4−〔4−(2−ハイドロ
オキシー3−イソプロピルアミノプロポキシ)フェニル
〕フタラジン600m9を用い、実施例1、hと同様な
反応を行ない1−ヒドラジノー4−〔4−(2−ハイド
ロオキシー3ーイソプロピルアミノプロポキシ)フェニ
ル〕フタラジン520m9(87.7%)を得た。Recrystallized from methanol, melting point 158-160°C. h1
1-hydrazino 4-[4-(2-hydroxy-3
The same reaction as in Example 1, h was carried out using 600 m9 of 1-chloro-4-[4-(2-hydroxy-3-isopropylaminopropoxy)phenyl]phthalazine obtained on -isopropylaminopropoxy)phenyl]phthalazine. 520 m9 (87.7%) of 1-hydrazino-4-[4-(2-hydroxy-3-isopropylaminopropoxy)phenyl]phthalazine were obtained.
融点127〜129℃(分解)。元素分析C2OH25
O2N5としてMelting point 127-129°C (decomposed). Elemental analysis C2OH25
As O2N5
Claims (1)
、フェニル基上の置換基はo、m、またはp位にあるこ
とを意味する)で表わされる化合物及びその塩。[Claims] 1 General formula ▲ Numerical formula, chemical formula, table, etc. ▼ (In the formula, R means a linear or branched lower alkyl group, and the substituents on the phenyl group are o, m, or (meaning being in the p-position) and salts thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP52098823A JPS6051473B2 (en) | 1977-08-18 | 1977-08-18 | 4-substituted phenyl phthalazine derivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP52098823A JPS6051473B2 (en) | 1977-08-18 | 1977-08-18 | 4-substituted phenyl phthalazine derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5432489A JPS5432489A (en) | 1979-03-09 |
JPS6051473B2 true JPS6051473B2 (en) | 1985-11-14 |
Family
ID=14230011
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP52098823A Expired JPS6051473B2 (en) | 1977-08-18 | 1977-08-18 | 4-substituted phenyl phthalazine derivatives |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6051473B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63155220U (en) * | 1987-03-31 | 1988-10-12 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1148053A4 (en) * | 1999-01-26 | 2002-03-06 | Ono Pharmaceutical Co | 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient |
-
1977
- 1977-08-18 JP JP52098823A patent/JPS6051473B2/en not_active Expired
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63155220U (en) * | 1987-03-31 | 1988-10-12 |
Also Published As
Publication number | Publication date |
---|---|
JPS5432489A (en) | 1979-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR930009793B1 (en) | Benzopyran derivatives and preparation methods thereof | |
US3936461A (en) | Substituted 4-benzylquinolines | |
EP0156331B1 (en) | Benzofuran derivatives, processes for preparing the same and antihypertensive agents containing the same | |
JPS6317870A (en) | Naphthalenesulfonamide derivative | |
SU1340585A3 (en) | Method of producing derivatives of tetrazole | |
JPS6051473B2 (en) | 4-substituted phenyl phthalazine derivatives | |
EP0243982B1 (en) | 1-acyl-2,3-dihydro-4(1h)-quinolinone-4-oxime derivative, process for the production thereof, pharmaceutical composition and intermediates | |
SE455701B (en) | SULFUROUS ISOQINOLINE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM | |
JPS6368568A (en) | P-aminophenol derivative | |
JPH0710863B2 (en) | Novel derivative of 4-OH quinolinecarboxylic acid substituted at position 2 with an etherifiable or esterifiable dihydroxy group, a process for its preparation and its use as a medicament | |
US3983126A (en) | Aryloxy pyridine carboxylic-4-acids | |
JPS6183163A (en) | Antitumoral | |
GB2126230A (en) | Substituted 1-pyridyloxy-3- indolylakylamino-2-propanols, preparation, and use thereof | |
KR900005021B1 (en) | 1-phenoxy-3-hydroxyindolyl-alkylamino-3-propanols and preparing process thereof | |
US3991082A (en) | 4-Substituted-2,3-dihydro-1-benzoxepin-3,5-diones and tautomers | |
US4001224A (en) | 4-substituted-2, 3-dihydro-1-benzoxepin-3, 5-diones and tautomers | |
KR820000099B1 (en) | Process for preparing pyrido (2,1-b)quinazoline derivatives | |
KR860000650B1 (en) | Method for preparing quinolone compound | |
CA1100504A (en) | S-triazolo [1,5-a] pyridine derivatives | |
CA1073913A (en) | Amphetamine derivatives | |
EP0393109A1 (en) | NOVEL 2,3-THIOMORPHOLINEDIONE-2-OXIME DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE DERIVATIVES AND PROCESS FOR THEIR PREPARATION. | |
KR820000100B1 (en) | Process for preparing pyrido (2,1-b)quinazoline derivatives | |
EP0050385B1 (en) | Piridoxine derivatives, a process for their preparation and related pharmaceutical compositions | |
CA1192192A (en) | Intermediates for the synthesis of phthalimidines | |
KR820000101B1 (en) | Process for preparing pyride (2,1-b)quinazoline derivatives |